2002
DOI: 10.1016/s0025-7753(02)73390-3
|View full text |Cite
|
Sign up to set email alerts
|

Eficacia y seguridad del sildenafilo en pacientes con disfunción eréctil e hipertensión arterial. Factores pronósticos de respuesta

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2003
2003
2017
2017

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 26 publications
0
2
0
Order By: Relevance
“…Hence we had to give up on a placebo for Yidiyin, as is common in the study of the decoctions in traditional Chinese medicine. Additionally, we did not design an inhibitor of PDE5 for Yidiyin as a control trial in the animal experiment either, because the drug is not completely effective for diabetic ED, 13,14) and was not chosen as a treatment for human patients in our clinical trial. In view of insulin deficiency in the diabetic ED rats, we also used insulin (Glargine) as a substitute for Metformin or Gliguidone.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Hence we had to give up on a placebo for Yidiyin, as is common in the study of the decoctions in traditional Chinese medicine. Additionally, we did not design an inhibitor of PDE5 for Yidiyin as a control trial in the animal experiment either, because the drug is not completely effective for diabetic ED, 13,14) and was not chosen as a treatment for human patients in our clinical trial. In view of insulin deficiency in the diabetic ED rats, we also used insulin (Glargine) as a substitute for Metformin or Gliguidone.…”
Section: Discussionmentioning
confidence: 99%
“…11,12) Moreover, quite a number of diabetic ED patients and diabetic rats show a poor response to PDE5 inhibitor therapy. 13,14) Hence the utilization of drugs is sharply limited, especially for patients with angiocardiopathy.…”
mentioning
confidence: 99%